National Research (NASDAQ:NRCIA) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Thursday.

Separately, Zacks Investment Research lowered National Research from a “hold” rating to a “strong sell” rating in a research report on Friday, November 10th.

National Research (NASDAQ:NRCIA) remained flat at $$33.80 during mid-day trading on Thursday. 17,277 shares of the company traded hands, compared to its average volume of 26,879. The firm has a market capitalization of $849.53, a PE ratio of 48.87 and a beta of 1.63. National Research has a 52 week low of $16.30 and a 52 week high of $41.99.

In related news, major shareholder K/I/E/Trust Under Agreement 3/ sold 2,127 shares of the stock in a transaction that occurred on Wednesday, October 25th. The stock was sold at an average price of $38.00, for a total value of $80,826.00. Following the completion of the transaction, the insider now directly owns 5,655,489 shares in the company, valued at $214,908,582. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold 134,715 shares of company stock valued at $4,996,670 over the last quarter. 37.54% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the business. Rice Hall James & Associates LLC raised its stake in shares of National Research by 1.0% in the second quarter. Rice Hall James & Associates LLC now owns 15,035 shares of the business services provider’s stock valued at $404,000 after acquiring an additional 155 shares in the last quarter. Schwab Charles Investment Management Inc. raised its stake in shares of National Research by 0.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 30,453 shares of the business services provider’s stock valued at $820,000 after acquiring an additional 190 shares in the last quarter. Neuberger Berman Group LLC raised its stake in shares of National Research by 0.9% in the second quarter. Neuberger Berman Group LLC now owns 58,637 shares of the business services provider’s stock valued at $1,577,000 after acquiring an additional 545 shares in the last quarter. WCM Investment Management CA raised its stake in shares of National Research by 0.8% in the second quarter. WCM Investment Management CA now owns 73,087 shares of the business services provider’s stock valued at $1,966,000 after acquiring an additional 580 shares in the last quarter. Finally, Alliancebernstein L.P. raised its stake in shares of National Research by 5.1% in the second quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock valued at $333,000 after acquiring an additional 600 shares in the last quarter. Institutional investors own 25.02% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “National Research (NRCIA) Lowered to Hold at BidaskClub” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/12/07/national-research-nrcia-lowered-to-hold-at-bidaskclub.html.

National Research Company Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Receive News & Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related companies with MarketBeat.com's FREE daily email newsletter.